OPINION: President Trump has stalled the confirmation process for Jay Clayton to be the next Director of National Intelligence, frustrating members of Congress. #Trump #JayClayton #SAVEAct
A Republican senator on Thursday expressed skepticism about the tentative agreement struck by Iran and the U.S., which replaces the previous Joint Comprehensive Plan of Action (JCPOA) dissolved under the first Trump administration. “They’re going to have to come explain this because we did have very serious problems with the JCPOA. I don’t want to see JCPOA 2.0,” Sen. Joni Ernst (R-Iowa), who sits on the Senate Armed Services Committee, told NewsNation’s Joe Khalil. #Ernst #Iran #War #Trump #MOU #MemorandumofUnderstanding READ MORE: https://thehill.com/homenews/senate/5931086-republican-senator-iran-agreement-concerns/
A narrow waterway, approximately 21 miles wide, controls the flow of the world’s oil and it’s become a flashpoint in an international conflict. This explainer breaks down why the Strait of Hormuz matters: the millions of barrels of oil that pass through daily, the geography that makes it a chokepoint, the mine threat lurking below, and how chaos here reaches gas pumps worldwide. 00:00 - Introduction 00:18 - Why the Strait of Hormuz Is Important 01:29 - The Cost of Every Delay 02:27 - The Importance Of The Straits Geography 03:40 - Sea Mines In The Strait 05:14 - Who Controls The Strait? NewsNation National Correspondent: Elizabeth Prann Executive Producer: Andy Gipson Editorial Producer: Meagan Ourada Segment Producer: Christine…
Get Gerry's latest takes on the hottest news and headlines from behind enemy lines in deep blue Boston on today's LIVE edition of The Gerry Callahan Show.
A growing number of GLP-1 users say they still see themselves as overweight even after losing significant weight. Experts call the phenomenon “ghost fat,” the latest psychological effect linked to the weight-loss revolution. Other reported side effects include “Ozempic face,” hair loss, muscle loss and mood changes.Do the benefits outweigh the side effects? And should the 41 million Americans using GLP-1 drugs be concerned?